Erratum to “Terminology of developmental abnormalities in common laboratory mammals (version 2)” [Reprod. Toxicol. 28 (2009) 371–434]

At thetimethattheVersion2terminologymanuscriptwaspublished,theauthorsinvitedalluserstosubmitcorrectionsandcomments.As of the current date, only 3 minor corrections have been identified. These are listed as follows:1. There was a misspelling in the company name for Yojiro Ooshima on page 371; the corrected affiliation is: Shin Nippon BiomedicalLaboratories, Ltd., Kagoshima, Japan.2. The company name for Meg Parkinson was mistakenly listed as GlaxoSmithKline Services on page 371; the correct company name isGlaxoSmithKline Pharmaceuticals.3. In the acknowledgements of the contributions of MARTA/MTA colleagues on page 375 the surname of Joyce Rendemonti was misspelled.The authors would like to apologise for any inconvenience this may have caused to the readers of the journal.